PharmaIN Corporation announced that it has entered into a security purchase agreement with new investor Shionogi & Co., Ltd. (TSE:4507) for gross proceeds of $17 million on January 4, 2018. The company will issue common stock in the transaction. The company will receive funding in three tranches.